Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06311123

Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis

Sponsor: University of California, San Diego

View on ClinicalTrials.gov

Summary

The goal of this observational study is to learn about the mechanism of action of ozanimod in patients with ulcerative colitis (UC). The main questions it aims to answer are: 1. Prospectively assess the effects of ozanimod on the cellular composition of intestinal lamina propria and blood by deep immunophenotyping (CyTOF) of immune cell subsets prior and after the drug's administration. 2. Determine whether changes in cell subsets observed via mass cytometry correlate with with clinical or histologic parameters of disease activity. Colonic biopsies and peripheral blood samples will be collected from patients with UC before and after the onset of ozanimod. Researchers will compare intestinal and peripheral leukocytes before and after the drug's administration.

Official title: High Dimensional Mass Cytometry as a Tool to Understand Ozanimod's Mechanism of Action (MOA)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

10

Start Date

2023-10-06

Completion Date

2026-09-30

Last Updated

2024-03-15

Healthy Volunteers

No

Locations (1)

University of California San Diego

San Diego, California, United States